A53T (p.Ala53Thr) variant of SGCA (Alpha-sarcoglycan)

A53T (p.Ala53Thr) in SGCA (Alpha-sarcoglycan) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as conflicting interpretations in the context of Autosomal recessive limb-girdle muscular dystrophy; not provided; Autosomal rece. The available variant effect predictions contribute to a CATVariant prioritization score of 0.54 / 1. The record also includes population frequency data and structural context.

A53T (p.Ala53Thr) variant details